1. Home
  2. OPK vs RAPP Comparison

OPK vs RAPP Comparison

Compare OPK & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.33

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

RAPP

Rapport Therapeutics Inc.

HOLD

Current Price

$30.76

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPK
RAPP
Founded
2007
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
1995
2024

Fundamental Metrics

Financial Performance
Metric
OPK
RAPP
Price
$1.33
$30.76
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$2.28
$47.80
AVG Volume (30 Days)
3.3M
467.2K
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$642,067,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$6.43
52 Week High
$2.04
$42.27

Technical Indicators

Market Signals
Indicator
OPK
RAPP
Relative Strength Index (RSI) 45.29 57.51
Support Level $1.29 $28.03
Resistance Level $1.37 $31.52
Average True Range (ATR) 0.05 2.03
MACD -0.00 0.12
Stochastic Oscillator 28.76 67.07

Price Performance

Historical Comparison
OPK
RAPP

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About RAPP Rapport Therapeutics Inc.

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: